New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense.
暂无分享,去创建一个
X. Shu | C. Bai | W. Wen | Pingsheng Wu | Gong Yang | M. Gross | T. Hartman | L. Roberts | T. Hartert | T. Gebretsadik | E. Larkin | M. Jin | Yu-Tang Gao | Yu-Tang Gao
[1] A. Hyvärinen,et al. Serum vitamin E concentrations at 1 year and risk of atopy, atopic dermatitis, wheezing, and asthma in childhood: the PASTURE study , 2014, Allergy.
[2] T. Hartert,et al. Two faces of vitamin E in the lung. , 2013, American journal of respiratory and critical care medicine.
[3] M. Kiray,et al. The Effect of Rupatadine on Lung Histopathology in a Murine Model of Chronic Asthma , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.
[4] Q. Husain,et al. Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma , 2012, Annals of thoracic medicine.
[5] L. Wood,et al. Manipulating antioxidant intake in asthma: a randomized controlled trial. , 2012, The American journal of clinical nutrition.
[6] Leena Choi,et al. Natural‐source d‐α‐tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo , 2012, Allergy.
[7] E. Fabian,et al. Activities of Antioxidant Enzymes in Relation to Oxidative and Nitrosative Challenges in Childhood Asthma , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.
[8] H. Abdala-Valencia,et al. Supplemental and Highly Elevated Tocopherol Doses Differentially Regulate Allergic Inflammation: Reversibility of α-Tocopherol and γ-Tocopherol’s Effects , 2011, The Journal of Immunology.
[9] D. Papakosta,et al. Alterations of erythrocyte superoxide dismutase activity in patients suffering from asthma attacks. , 2010, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[10] H. Abdala-Valencia,et al. Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment (The Journal of Immunology (2009) 182, (4395-4405)) , 2010 .
[11] L. Wood,et al. Reduced circulating antioxidant defences are associated with airway hyper-responsiveness, poor control and severe disease pattern in asthma. , 2010, The British journal of nutrition.
[12] F. Raffi,et al. Evaluation of the tuberculin skin test and the interferon-γ release assay for TB screening in French healthcare workers , 2009, Journal of occupational medicine and toxicology.
[13] J. Leonardi-Bee,et al. Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis , 2009, Thorax.
[14] E. Israel,et al. Noninvasive Markers of Airway Inflammation in Asthma , 2009, Clinical and translational science.
[15] F. Clavel-Chapelon,et al. Dietary patterns and asthma in the E3N study , 2009, European Respiratory Journal.
[16] O. Kalayci,et al. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. , 2008, The Journal of allergy and clinical immunology.
[17] X. Shu,et al. The Shanghai Women's Asthma and Allergy Study: objectives, design, and recruitment results. , 2008, American Journal of Epidemiology.
[18] A. Nel,et al. Importance of oxidative stress in the pathogenesis and treatment of asthma , 2008, Current opinion in allergy and clinical immunology.
[19] L. Wood,et al. Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: Proof of concept , 2008, Free radical research.
[20] T. Bucciarelli,et al. Plasma Lycopene and Antioxidant Vitamins in Asthma: the PLAVA Study , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.
[21] K. Karasawa. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. , 2006, Biochimica et biophysica acta.
[22] A. Mokdad,et al. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. , 2006, The American journal of clinical nutrition.
[23] A. Mokdad,et al. Distribution of serum concentrations of α-tocopherol and γ-tocopherol in the US population , 2006 .
[24] H. Schünemann,et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD , 2006, European Journal of Clinical Nutrition.
[25] C. Cunningham,et al. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. , 2006, Analytical biochemistry.
[26] L. Wood,et al. Airway and Circulating Levels of Carotenoids in Asthma and Healthy Controls , 2005, Journal of the American College of Nutrition.
[27] N. Rothman,et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.
[28] W. Busse,et al. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. , 2005, American journal of respiratory and critical care medicine.
[29] A. Seaton,et al. Diet as a risk factor for atopy and asthma. , 2005, The Journal of allergy and clinical immunology.
[30] M. Chan-yeung,et al. Systemic oxidative and antioxidative status in Chinese patients with asthma. , 2004, The Journal of allergy and clinical immunology.
[31] R. Bowler. Oxidative stress in the pathogenesis of asthma , 2004, Current allergy and asthma reports.
[32] P. Cassano,et al. Relationship of serum antioxidants to asthma prevalence in youth. , 2004, American journal of respiratory and critical care medicine.
[33] D. Mannino,et al. Serum Antioxidant Concentrations Among U.S. Adults with Self‐Reported Asthma , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.
[34] C. Abnet,et al. Prospective study of serum vitamin E levels and esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.
[35] P. Gibson,et al. Biomarkers of lipid peroxidation, airway inflammation and asthma , 2003, European Respiratory Journal.
[36] T. Arinami,et al. Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma , 2002, Journal of Human Genetics.
[37] J. Morrow,et al. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2‐isoprostane, 15‐F2t‐IsoP (8‐iso‐PGF2α) , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[38] P. Barnes,et al. Elevation of exhaled ethane concentration in asthma. , 2000, American journal of respiratory and critical care medicine.
[39] L. Wood,et al. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma , 2000, Lipids.
[40] K. Deichmann,et al. The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. , 2000, American journal of human genetics.
[41] M. Tockman,et al. Serum tocopherols, selenium and lung cancer risk among tin miners in China , 2000, Cancer Causes & Control.
[42] J. Barberà,et al. Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study. , 1999, The European respiratory journal.
[43] T. Fukuda,et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. , 1999, The Journal of clinical investigation.
[44] K. Enzan,et al. PLATELET‐ACTIVATING FACTOR IS A KEY MEDIATOR OF PULMONARY VASOCONSTRICTION AND BRONCHOCONSTRICTION AFTER ANTIGEN CHALLENGE IN THE PERFUSED SENSITIZED RABBIT LUNG , 1998, Shock.
[45] V. Peinado,et al. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. , 1998, The European respiratory journal.
[46] R. Elswick,et al. Interpretation of the odds ratio from logistic regression after a transformation of the covariate vector. , 1997, Statistics in medicine.
[47] P. Barnes,et al. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. , 1997, American journal of respiratory and critical care medicine.
[48] R. Louis,et al. Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. , 1996, The European respiratory journal.
[49] M. Yamakido,et al. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. , 1995, American journal of respiratory and critical care medicine.
[50] F. Speizer,et al. A prospective study of diet and adult-onset asthma. , 1995, American journal of respiratory and critical care medicine.
[51] K. Chung,et al. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. , 1995, American journal of respiratory and critical care medicine.
[52] P. Calverley,et al. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. , 1994, American journal of respiratory and critical care medicine.
[53] P. O'Byrne,et al. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. , 1993, Thorax.
[54] T. Takishima,et al. Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs. , 1992, Journal of lipid mediators.
[55] K. Hsieh. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children. , 1991, Chest.
[56] H. Heuer,et al. Inhibitory effects of the new PAF acether antagonist WEB‐2086 on pharmacologic changes induced by PAF inhalation in human beings , 1990, Clinical pharmacology and therapeutics.
[57] K. Chung,et al. Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings. , 1989, Allergy proceedings : the official journal of regional and state allergy societies.
[58] M. A. Bray,et al. Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. , 1987, European journal of pharmacology.
[59] F. Cuss,et al. EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MAN , 1986, The Lancet.
[60] J. C. Smith,et al. Determination of Individual Carotenoids in Human Plasma by High Performance Liquid Chromatography , 1985 .
[61] S. Pilz,et al. The challenge of setting appropriate intake recommendations for vitamin E: considerations on status and functionality to define nutrient requirements. , 2013, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[62] S. Hazen,et al. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. , 2005, The American journal of pathology.
[63] K. Asano,et al. Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. , 1999, American journal of respiratory and critical care medicine.
[64] L. Smith,et al. Reduced superoxide dismutase in lung cells of patients with asthma. , 1997, Free radical biology & medicine.
[65] T. Miyamoto,et al. Effect of a potent platelet-activating factor antagonist, WEB-2086, on asthma. A multicenter, double-blind placebo-controlled study in Japan. , 1996, Advances in experimental medicine and biology.
[66] K. P. Hui,et al. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen. , 1993, The American review of respiratory disease.
[67] D. Stafforini,et al. Platelet-activating factor acetylhydrolase from human plasma. , 1990, Methods in enzymology.
[68] J. C. Smith,et al. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. , 1988, Clinical chemistry.